• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

EIDD-2801 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759116

EIDD-2801 is an isopropylester prodrug of the ribonucleoside analog N 4-hydroxycytidine (EIDD-1931) that has shown broad influenza virus and multiple coronaviruses activity. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
EIDD-2801, Inhibitor
Full Product Name
EIDD-2801
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
100.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
329.31
Solubility
DMSO: 100mg/mL (303.67mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C13H19N3O7
SMILES
CC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=NO)[nH]c1=O
CAS Number
2349386-89-4
Target & IC50
SARS-CoV

Product Categories/Family for EIDD-2801, inhibitor

Structure of EIDD-2801, inhibitor

EIDD-2801 Inhibitor – Cat# MBS5759116

Product References and Citations for EIDD-2801, inhibitor

Toots M, et al. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci Transl Med. 2019 Oct 23;11(515). pii: eaax5866.
Toots M, et al. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci Transl Med. 2019 Oct 23;11(515). pii: eaax5866.
Mart Toots, Jeong-Joong Yoon, Michael Hart,et al.Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model.ransl Res. 2020 Apr;218:16-28.
Mart Toots, Jeong-Joong Yoon, Michael Hart,et al.Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model.ransl Res. 2020 Apr;218:16-28.
Sheahan TP, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020 Apr 6. pii: eabb5883.
Sheahan TP, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020 Apr 6. pii: eabb5883.

Other Notes

Small volumes of EIDD-2801, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for EIDD-2801 purchase

MBS5759116 is an inhibitor targeting EIDD-2801.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000